Digestives & Intestinal Remedies - Turkey

Turkey

Highlights

In 2024, the Digestives & Intestinal Remedies market market in Turkey is projected to generate a revenue of US$15.74m.
This market is anticipated to experience an annual growth rate of 1.42% (CAGR 2024-2029).
When compared to other countries worldwide, China leads the pack with a revenue of US$4.41bn in 2024.
Taking into account the total population, the per person revenue in Turkey is estimated to be US$0.18 in 2024.
Turkey is experiencing a growing demand for natural digestive remedies, with consumers seeking herbal and plant-based options for their gastrointestinal health.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestives & Intestinal Remedies market in Turkey is experiencing steady growth due to customer preferences for natural and herbal remedies, as well as an increasing awareness of digestive health.

Customer preferences: Customers in Turkey are increasingly seeking natural and herbal remedies for digestive issues. This preference for natural products is driven by a growing awareness of the potential side effects of synthetic medications and a desire for more holistic approaches to healthcare. Additionally, customers are becoming more proactive in managing their digestive health and are willing to invest in products that can help prevent and alleviate common digestive issues.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in Turkey is the growing demand for probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They can help restore the natural balance of bacteria in the gut and alleviate symptoms such as bloating, constipation, and diarrhea. Probiotics are increasingly being incorporated into a variety of products, including yogurts, drinks, and supplements, to cater to the growing demand.Another trend in the market is the rise of digestive enzyme supplements. These supplements contain enzymes that help break down food and improve digestion. They are particularly popular among individuals with specific dietary restrictions or digestive disorders, such as lactose intolerance or irritable bowel syndrome. The convenience and effectiveness of these supplements make them a popular choice among consumers.

Local special circumstances: Turkey has a rich tradition of herbal medicine, which has influenced customer preferences in the Digestives & Intestinal Remedies market. Turkish consumers have a long history of using herbal remedies for various health issues, including digestive problems. This cultural heritage has contributed to the popularity of natural and herbal remedies in the market.Additionally, the Turkish government has been actively promoting the use of herbal medicine and traditional remedies. This has created a favorable environment for the growth of the Digestives & Intestinal Remedies market, as consumers have access to a wide range of natural and herbal products.

Underlying macroeconomic factors: The growing Digestives & Intestinal Remedies market in Turkey can also be attributed to the country's improving economy and rising disposable incomes. As the economy continues to grow, consumers have more purchasing power and are willing to spend on healthcare products and supplements. This has created a favorable market environment for the Digestives & Intestinal Remedies industry to thrive.Furthermore, the increasing prevalence of digestive issues, such as indigestion, acid reflux, and irritable bowel syndrome, is driving the demand for remedies in Turkey. Factors such as changing dietary habits, stress, and sedentary lifestyles contribute to the high incidence of digestive problems among the population. As a result, there is a growing need for effective solutions to address these issues, which is fueling the growth of the Digestives & Intestinal Remedies market in Turkey.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.